Christopher Lee, MD
Advertisement
Articles by Christopher Lee, MD
Advertisement
Latest Updated Articles
Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancerPublished: October 2nd 2025 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5
